Ørjan Samuelsen

Ørjan Samuelsen

Auto-generated profile, based on publicly available information

Ørjan Samuelsen

Norwegian Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
RCR. Cantón
R. Cantón
Murat AkovaMurat Akova
Murat Akova
YCY. Carmeli
Y. Carmeli
CGC.G. Giske
C.G. Giske
YGY. Glupczynski
Y. Glupczynski
PNP. Nordmann
P. Nordmann

1 February 2017 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
HGHajo Grundmann
Hajo Grundmann
CGCorinna Glasner
Corinna Glasner
BABarbara Albiger
Barbara Albiger
DADavid M Aanensen
David M Aanensen
CTChris T Tomlinson
Chris T Tomlinson
DBDerek J. Brown
Derek J. Brown

1 January 2017 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
MEM.J. Ellington
M.J. Ellington
OEO. Ekelund
O. Ekelund
FAFrank Møller Aarestrup
Frank Møller Aarestrup
RCR. Canton
R. Canton
MDM. Doumith
M. Doumith
NWN. Woodford
N. Woodford

1 August 2012 in Drug Resistance Updates
Verified
Journal Article
Closed access
NKNabil Karah
Nabil Karah
ASArnfinn Sundsfjord
Arnfinn Sundsfjord
KTKevin Towner
Kevin Towner
ØSØrjan Samuelsen
Ørjan Samuelsen

1 April 2011 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PDF file
CGC. G. Giske
C. G. Giske
LGL. Gezelius
L. Gezelius
ØSØ. Samuelsen
Ø. Samuelsen
MWM. Warner
M. Warner
ASArnfinn Sundsfjord
Arnfinn Sundsfjord
NWN. Woodford
N. Woodford

13 February 2009 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
ØSØrjan Samuelsen
Ørjan Samuelsen
UNUmaer Naseer
Umaer Naseer
STStåle Tofteland
Ståle Tofteland
DSDag Harald Skutlaberg
Dag Harald Skutlaberg
AOAnnette Onken
Annette Onken
CGChristian G. Giske
Christian G. Giske
The class A carbapenemase KPC has disseminated rapidly worldwide, challenging the treatment of Gram-negative infections. This report describes the first KPC-producing Klebsiella pneumoniae isolates identified in Norway (n=6) and the second isolate from Sweden. Antimicrobial susceptibility profiles were determined using Etest. PCR and sequencing were used to determine the blaKPC variant, the surrounding genetic structure and the presence of AmpC and extended-spectrum β-lactamase genes. PFGE and multilocus sequence typing (MLST) were used for epidemiological comparisons. Localization of blaKPC was investigated by S1 nuclease digestion, followed by PFGE and Southern blot hybridization. All isolates expressed a multidrug-resistant phenotype with some variability in the carbapenem susceptibility profile. The Norwegian isolates carried blaKPC-2, while the Swedish isolate carried blaKPC-3. All isolates carried TEM-1, but were negative for blaCTX-M and blaAmpC genes. SHV-11 and SHV-12 were detected in the Norwegian isolates, while the Swedish isolate carried only SHV-11. Isolates from four patients were associated with import from Greece (n=3) and Israel. The other isolates were probably associated with local transmissions. PFGE and MLST showed that the isolates were clonally related, with three isolates displaying ST258, a single locus variant of ST11 previously associated with the clonal spread of CTX-M-15-producing K. pneumoniae in Hungary. In all isolates, blaKPC was located on plasmids as part of isoform a of Tn4401. The emergence of KPC-producing isolates of K. pneumoniae in Norway and Sweden is associated with multiple import events and probable local transmission of a successful multiresistant ST258 clone, closely related to the CTX-M-15-producing ST11 clone previously described in Hungary.